Genetic identification of AChE as a positive modulator of addiction to the psychostimulant D-amphetarnine in zebrafish

被引:77
作者
Ninkovic, J
Folchert, A
Makhankov, YV
Neuhauss, SCF
Sillaber, I
Straehle, U
Bally-Cuif, L
机构
[1] Tech Univ Munich, Inst Virol, Zebrafish Neurogenet Jr Res Grp, D-81675 Munich, Germany
[2] GSF, Natl Res Ctr Environm & Hlth, Dept Zebrafish Neurogenet, Inst Dev Genet, D-85764 Neuherberg, Germany
[3] Univ Zurich, Brain Res Inst, CH-8057 Zurich, Switzerland
[4] ETH, CH-8057 Zurich, Switzerland
[5] Max Planck Inst Psychiat, D-80804 Munich, Germany
[6] Forschungszentrum Karlsruhe, Inst Genet & Toxikol, D-76021 Karlsruhe, Germany
[7] Heidelberg Univ, D-76021 Karlsruhe, Germany
来源
JOURNAL OF NEUROBIOLOGY | 2006年 / 66卷 / 05期
关键词
D O I
10.1002/neu.20231
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Addiction is a complex maladaptive behavior involving alterations in several neurotransmitter networks. In mammals, psychostimulants trigger elevated extracellular levels of dopamine, which can be modulated by central cholinergic transmission. Which elements of the cholinergic system might be targeted for drug addiction therapies remains unknown. The rewarding properties of drugs of abuse are central for the development of addictive behavior and are most commonly measured by means of the conditioned place preference (CPP) paradigm. We demonstrate here that adult zebrafish show robust CPP induced by the psychostimulant D-amphetamine. We further show that this behavior is dramatically reduced upon genetic impairment of acetylcholinesterase (AChE) function in ache/+ mutants, without involvement of concomitant defects in exploratory activity, learning, and visual performance. Our observations demonstrate that the cholinergic system modulates drug-induced reward in zebrafish, and identify genetically AChE as a promising target for systemic therapies against addiction to psychostimulants. More generally, they validate the zebrafish model to study the effect of developmental mutations on the molecular neurobiology of addiction in vertebrates. (c) 2006 Wiley Periodicals, Inc.
引用
收藏
页码:463 / 475
页数:13
相关论文
共 46 条
[1]   Localization of dopamine D2 receptors on cholinergic interneurons of the dorsal striatum and nucleus accumbens of the rat [J].
Alcantara, AA ;
Chen, V ;
Herring, BE ;
Mendenhall, JM ;
Berlanga, ML .
BRAIN RESEARCH, 2003, 986 (1-2) :22-29
[2]   Neurotransmitter transporters as molecular targets for addictive drugs [J].
Amara, SG ;
Sonders, MS .
DRUG AND ALCOHOL DEPENDENCE, 1998, 51 (1-2) :87-96
[3]   5-HT2A and α1b-adrenergic receptors entirely mediate dopamine release, locomotor response and behavioural sensitization to opiates and psychostimulants [J].
Auclair, A ;
Drouin, C ;
Cotecchia, S ;
Glowinski, J ;
Tassin, JP .
EUROPEAN JOURNAL OF NEUROSCIENCE, 2004, 20 (11) :3073-3084
[4]   The use of zebrafish mutants to identify secondary target effects of acetylcholine esterase inhibitors [J].
Behra, M ;
Etard, C ;
Cousin, X ;
Strähle, U .
TOXICOLOGICAL SCIENCES, 2004, 77 (02) :325-333
[5]   Acetylcholinesterase is required for neuronal and muscular development in the zebrafish embryo [J].
Behra, M ;
Cousin, X ;
Bertrand, C ;
Vonesch, JL ;
Biellmann, D ;
Chatonnet, A ;
Strähle, U .
NATURE NEUROSCIENCE, 2002, 5 (02) :111-118
[6]   Cholinergic elements in the zebrafish central nervous system: Histochemical and immunohistochemical analysis [J].
Clemente, D ;
Porteros, K ;
Weruaga, E ;
Alonso, JR ;
Arenzana, FJ ;
Aijón, J ;
Arévalo, R .
JOURNAL OF COMPARATIVE NEUROLOGY, 2004, 474 (01) :75-107
[7]   Behavioral screening for cocaine sensitivity in mutagenized zebrafish [J].
Darland, T ;
Dowling, JE .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2001, 98 (20) :11691-11696
[8]   Septal GABAergic and hippocampal cholinergic systems interact in the modulation of anxiety [J].
DeGroot, A ;
Treit, D .
NEUROSCIENCE, 2003, 117 (02) :493-501
[9]   Dorsal and ventral hippocampal cholinergic systems modulate anxiety in the plus-maze and shock-probe tests [J].
Degroot, A ;
Treit, D .
BRAIN RESEARCH, 2002, 949 (1-2) :60-70
[10]   Infusions of physostigmine into the hippocampus or the entorhinal cortex attenuate avoidance retention deficits produced by intra-septal infusions of the GABA agonist muscimol [J].
Degroot, A ;
Parent, MB .
BRAIN RESEARCH, 2001, 920 (1-2) :10-18